Evidence map›Paper›PMID 27651486›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

2-(m-Azidobenzoyl)taxol binds differentially to distinct β-tubulin isotypes.

Chia-Ping Huang Yang, Eng-Hui Yap, Hui Xiao, Andras Fiser, Susan Band Horwitz

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Small molecule photocatalysis enables drug target identification via energy transfer.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Review
  9. The Effect of Tau and Taxol on Polymerization of MCF7 Microtubules In Vitro.International journal of molecular sciences · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in pharmacology · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chia-Ping Huang YangDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461; Department of Obstetrics and Gynecology and Women's Health, Division of Gynecologic Oncology, Albert Einstein College of Medicine, Bronx, NY 10461; chia-ping.h.yang@einstein.yu.edu susan.horwitz@einstein.yu.edu.
Eng-Hui YapDepartment of System and Computational Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
Hui XiaoLaboratory of Macromolecular Analysis and Proteomics, Albert Einstein College of Medicine, Bronx, NY 10461.
Andras FiserDepartment of System and Computational Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
Susan Band HorwitzDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461; chia-ping.h.yang@einstein.yu.edu susan.horwitz@einstein.yu.edu.
Albert Einstein College of Medicine · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
TAXOL--MECHANISMS OF ACTION AND RESISTANCER01CA077263 · NCI · YESHIVA UNIVERSITY · PI HORWITZ, SUSAN BAND, MCDAID, HAYLEY M. · 1998 to 2019
$7.8M
NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA077263
6 · The paper itself

Abstract

There are seven β-tubulin isotypes present in distinct quantities in mammalian cells of different origin. Altered expression of β-tubulin isotypes has been reported in cancer cell lines resistant to microtubule stabilizing agents (MSAs) and in human tumors resistant to Taxol. To study the relative binding affinities of MSAs, tubulin from different sources, with distinct β-tubulin isotype content, were specifically photolabeled with a tritium-labeled Taxol analog, 2-(m-azidobenzoyl)taxol, alone or in the presence of MSAs. The inhibitory effects elicited by these MSAs on photolabeling were distinct for β-tubulin from different sources. To determine the exact amount of drug that binds to different β-tubulin isotypes, bovine brain tubulin was photolabeled and the isotypes resolved by high-resolution isoelectrofocusing. All bands were analyzed by mass spectrometry following cyanogen bromide digestion, and the identity and relative quantity of each β-tubulin isotype determined. It was found that compared with other β-tubulin isotypes, βIII-tubulin bound the least amount of 2-(m-azidobenzoyl)taxol. Analysis of the sequences of β-tubulin near the Taxol binding site indicated that, in addition to the M-loop that is known to be involved in drug binding, the leucine cluster region of βIII-tubulin contains a unique residue, alanine, at 218, compared with other isotypes that contain threonine. Molecular dynamic simulations indicated that the frequency of Taxol-accommodating conformations decreased dramatically in the T218A variant, compared with other β-tubulins. Our results indicate that the difference in residue 218 in βIII-tubulin may be responsible for inhibition of drug binding to this isotype, which could influence downstream cellular events.

Indexed as

Amino Acid SequenceAnimalsAntineoplastic Agents, PhytogenicBinding SitesHeLa CellsHumansMutationPolymerizationProtein DomainsProtein IsoformsSequence AlignmentTaxoidsTubulin2-(4-azidobenzoyl)taxolAntineoplastic Agents, PhytogenicProtein IsoformsTaxoidsTubulindrug bindingmicrotubule stabilizing agentsphotolabelingTaxoltubulin isotypes

Identifiers

PMID27651486
PMCPMC5056068
OpenAlexW2523269553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.